CHRISTINA LAKE CANNABIS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.04 CAD | -11.11% |
|
-11.11% | +33.33% |
| Sales 2021 | 3.63 4.97 | Sales 2022 | 10.07 13.78 | Capitalization | 13.09M 17.91M |
|---|---|---|---|---|---|
| Net income 2021 | -7M -9.58M | Net income 2022 | -2M -2.74M | EV / Sales 2021 | 11,658,831 x |
| Net Debt 2021 | 7.59M 10.39M | Net Debt 2022 | 4.61M 6.31M | EV / Sales 2022 | 1,756,705 x |
| P/E ratio 2021 |
-4.55
x | P/E ratio 2022 |
-6.19
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 82.57% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -11.11% | ||
| 1 week | -11.11% | ||
| Current month | -11.11% | ||
| 1 month | -11.11% | ||
| 6 months | +33.33% | ||
| Current year | +33.33% |
1 week
0.04
0.05
1 month
0.040.05
Current year
0.040.13
1 year
0.020.13
3 years
0.020.64
5 years
0.021.10
10 years
0.021.10
| Managers | Title | Age | Since |
|---|---|---|---|
Mark Aiken
CEO | Chief Executive Officer | - | 22-09-15 |
Ryan Smith
DFI | Director of Finance/CFO | - | 20-02-29 |
Salvatore Milia
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gil Playford
BRD | Director/Board Member | 75 | 20-12-15 |
Joel Dumaresq
BRD | Director/Board Member | 60 | 18-01-31 |
| Director/Board Member | 45 | 07-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-01 | 0.04 | -11.11% | 123,000 |
| 24-04-30 | 0.045 | +12.50% | 24,076 |
Delayed Quote Canadian Securities Exchange, May 01, 2024 at 01:09 pm EDT
More quotes
Christina Lake Cannabis Corp. is a Canada-based licensed producer of cannabis. The Company is a licensed cannabis producer with a cultivation, processing, research and development, and sales license from Health Canada. The Company is engaged in the processing of its stock of dried Cannabis biomass into various extracts including distilled and winterized oils, kief, and additional extracted products for sale to other licensed producers. Its facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. The Company also owns an approximately 99-acre plot of land adjoining its principal site. It focuses its production on creating extracts and distillates for its business-to-business client base with proprietary strains specifically developed for outdoor cultivation. The Company's Midway property consists of a total of 342 acres.
Sector
Pharmaceuticals
Calendar
2024-07-30
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +33.33% | 3.83M | |
| +39.75% | 4.17B | |
| +148.03% | 2.33B | |
| +138.10% | 78.45M |
- Stock Market
- Equities
- CLC Stock
